IGF-1 LR3 Peptide (0.1mg / 1mg)

Overview

IGF-1 LR3 peptide (Insulin-like Growth Factor 1 Long R3) is a modified version of human IGF-1 with an extended half-life. Through substitution of arginine for glutamic acid at position 3 and a 13-amino acid N-terminal extension, IGF-1 LR3 demonstrates increased stability and reduced binding to IGF-binding proteins. This makes it a powerful research tool for studying muscle growth, glucose regulation, and cell proliferation in preclinical models.

Compound Breakdown

• IGF-1 LR3 (0.1mg / 1mg): Modified insulin-like growth factor analog with extended half-life. Investigated for cellular proliferation, muscle repair, and glucose metabolism studies.

Research Applications

Preclinical research with IGF-1 LR3 peptide has explored:

• Muscle Growth and Repair → studied for satellite cell activation, protein synthesis, and hypertrophy models.

• Cellular Proliferation → investigated for tissue regeneration and repair processes.

• Glucose Regulation → studied for insulin-like effects on glucose uptake and metabolism.

• Neuroprotection → explored for potential influence on neuronal survival and repair.

• Comparative Studies → evaluated against native IGF-1 for stability, receptor affinity, and bioavailability in research models.

Related Categories

IGF-1 LR3 is part of the Muscle & Physique category. It is sometimes studied alongside Tesamorelin and Ipamorelin in anabolic and metabolic research models.

Compliance Statement

All Not Labs products are strictly for research use only and are not intended for human or veterinary use.